Abbott + Jiaxing Economic and Technological Development Zone
Abbott
Abbott Park, Illinois · 1 relationship
Active relationship
Wholly-Owned · 2011–present
Jiaxing Economic and Technological Development Zone
Jiaxing, Zhejiang · 1 relationship
Analysis
Abbott announced in August 2011 that it would invest $230 million in a nutrition-products manufacturing facility in Jiaxing, Zhejiang. The company described the project as its largest investment in China at the time and expected it to employ about 300 people, reflecting a strategy to add local production capacity as its Chinese nutrition business grew. [1]
The facility was designed as an integrated site for producing powdered infant formula and children's nutritional products. Abbott's China citizenship report identified the investment as approximately RMB 1.4 billion, while the company's China history records the Jiaxing plant as a major local manufacturing commitment. [2] [3]
Abbott opened the plant in June 2014, several years after announcing and constructing it in the Jiaxing Economic and Technological Development Zone. The operating partnership here is therefore best understood as place-based industrial cooperation: Abbott supplied capital, manufacturing systems and nutrition-product expertise, while Jiaxing's development zone hosted and supported a long-term production base serving China's domestic market. [3] [4]
Participants
Continue through either entity
Abbott Park, Illinois · 1 record in this database
Abbott Laboratories is an Illinois corporation whose principal business is discovering, developing, manufacturing and selling a diversified range of healthcare products. Abbott's public history dates to 1888, when a small Chicago pharmacy grew into a global healthcare company; its corporate headquarters are in Abbott Park, Illinois. [1] [2]
For 2025 reporting, Abbott organized its business into four reportable segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Medical Devices. The segments cover branded generic medicines sold outside the United States, diagnostic systems and tests, adult and pediatric nutrition, and devices spanning rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care. [1]
The Medical Devices portfolio includes FreeStyle Libre continuous glucose monitoring, CardioMEMS heart-failure monitoring, Aveir leadless pacemakers and structural-heart products such as MitraClip, which Abbott describes as a minimally invasive transcatheter valve-repair therapy. Abbott's 2025 filing reports $7.6 billion in continuous-glucose-monitoring sales, up 17.4% excluding foreign exchange from 2024, while the company's newsroom says the Libre systems were used by about seven million people. [1] [3]
Abbott reports that its products and solutions serve people in more than 160 countries and that it reaches more than two billion people, supported by approximately 122,000 employees worldwide. Taken together, its business combines laboratory diagnostics, nutrition, medicines and medical technologies across both routine care and complex chronic conditions. [2] [1]
Jiaxing Economic and Technological Development Zone
Jiaxing, Zhejiang · 1 record in this database
Jiaxing Economic and Technological Development Zone is an urban development zone in the main city area of Jiaxing, Zhejiang Province. The zone was established in August 1992 as one of the first provincial economic development zones approved by the Zhejiang government and was upgraded to national-level economic and technological development zone status in March 2010 with State Council approval. [1] [2]
The zone’s current official overview describes a planned control area of 110 square kilometers, management of four subdistricts, and a resident population of more than 350,000. An English-language government profile places the zone in downtown Jiaxing, describes it as a city-centered development zone, and identifies modern manufacturing and modern services as its principal areas of focus. [1] [2]
Jiaxing’s location gives the zone a regional role within the Yangtze River Delta. The government profile places it near Shanghai, Hangzhou, Suzhou and Ningbo and notes connections through the Shanghai-Hangzhou high-speed railway and expressway. The zone’s own transport-planning page presents a high-speed-rail metropolitan area intended to combine station development with business, exhibitions, tourism services and international commercial facilities. [2] [3]
The 2025 official overview reports that, in 2024, the zone’s GDP grew 5.8%, its above-designated-size industrial output reached RMB89.392 billion, and its above-designated-size industrial value added reached RMB18.623 billion. It identifies intelligent manufacturing, life and health, and new energy and materials among the area’s active industrial clusters, while the Jiaxing Intelligence and Innovation Park focuses on headquarters and digital economies and on Internet-of-Things and integrated-circuit industries. [1] [4]